GBP/USD 1.354 EUR/GBP 0.862 GBP/JPY 199.673 EUR/USD 1.168 GBP/AUD 2.079 USD/JPY 147.424 USD/CAD 1.379 AUD/USD 0.652 CAD/JPY 106.872 EUR/CAD 1.611 GBP/CAD 1.868 AUD/CAD 0.899 AUD/JPY 96.047 AUD/NZD 1.097 EUR/AUD 1.793 GBP/USD 1.354 EUR/GBP 0.862 GBP/JPY 199.673 EUR/USD 1.168 GBP/AUD 2.079 USD/JPY 147.424 USD/CAD 1.379 AUD/USD 0.652 CAD/JPY 106.872 EUR/CAD 1.611 GBP/CAD 1.868 AUD/CAD 0.899 AUD/JPY 96.047 AUD/NZD 1.097 EUR/AUD 1.793
CURRENCY .wiki

Finance News – Pharma

What is your interest today?

Quartz • Jul 15, 2025

Pharma tariffs would hit uninsured Americans the hardest, experts warn

Imposing tariffs on pharmaceutical imports could increase medication costs, disproportionately affecting those without insurance who rely on affordable generic drugs sourced primar...

Read Full Article →
City A.M. • Jul 09, 2025

Trump tariffs: FTSE 100 holds steady as pharma and metals brace for levies

The anticipation of upcoming trade duties on pharmaceutical and metal industries has prompted cautious market reactions, while the leading UK stock index maintained stability amid...

Read Full Article →
Business Insider Markets • Jun 03, 2025

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...

Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...

Read Full Article →
Quartz • May 30, 2025

How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Despite its initial leadership in the growing weight loss medication sector, Novo Nordisk has recently experienced a decline in market share compared to Eli Lilly, affecting its fi...

Read Full Article →
Quartz • May 12, 2025

Eli Lilly stock sinks as pharma misses out on the market rally

Eli Lilly experienced a notable decline in share value as broader pharmaceutical stocks failed to benefit from the market’s upward movement, influenced by new government policies o...

Read Full Article →